DAVID LEKBERG: Open Payments
NPI 1588925168 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $81 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Indivior Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: INGREZZA, SUBLOCADE, COBENFY, CAPLYTA, ABILIFY MAINTENA, UZEDY, VRAYLAR, Jornay PM.
Industry payments across VA — which companies pay providers there.
